JCB logo
BD Biosciences Cell Culture Solutions
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 13 October 2003. doi:10.1083/jcb1632iti3
This Article
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2003/10/11 $8.00
The Journal of Cell Biology, Volume 163, Number 1, 11-11


In This Issue

To kill a brain cell


High levels of APP-BP1 (white), as found in Alzheimer's patients (right), kills neurons.

The consequences of amyloid formation by the amyloid precursor protein (APP) in Alzheimer's disease (AD) have been the focus of many studies, yet little is known about the nonpathogenic function of APP. On page 27, some progress is made in this direction by Chen et al., who show that APP induces a suicide pathway in neurons.

APP initiates this death-inducing cascade when it encounters the binding protein APP-BP1. High levels of APP in neurons, or the APP mutant version associated with AD, promoted the recruitment of APP-BP1 to lipid rafts and activated its death-inducing activity. Past in vitro work has shown that APP-BP1 activates the ubiquitin-like protein NEDD8. NEDD8 conjugation of proteins such as Cullin (part of the SCF complex) drives entry into the cell cycle. In neurons, this push into mitosis somehow causes cell death rather than division. Chen et al. show that the APP-induced death also requires NEDD8 activation, as well as interaction of APP-BP1 with an intracellular domain of APP.

Unusually high levels of APP-BP1 and active NEDD8 were found in brain tissue from AD patients. Thus, constitutive activation of APP-BP1–mediated cell death may contribute to AD. The authors speculate that, under normal conditions, APP-BP1 remains inactive unless APP is bound by some as-yet unidentified extracellular ligand. The physiological relevance of this neuronal death program is unknown, but cloning of the APP ligand may offer some insight. {blacksquare}



Nicole LeBrasseur

lebrasn{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain
Yuzhi Chen, Wenyun Liu, Donna L. McPhie, Linda Hassinger, and Rachael L. Neve
J. Cell Biol. 2003 163: 27-33. [Abstract] [Full Text] [PDF]




This Article
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LeBrasseur, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LeBrasseur, N.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents